Showing results (141-150 of 451) with videos related to
Sort By:
Pageof 46
Journal of Scleroderma and Related Disorders|April 6, 2022
COVID-19 and systemic sclerosis: Rising to the challenge of a pandemicChristopher P Denton, Corrado Campochiaro, Cosimo Bruni, et al.RMD Open|October 17, 2025
Nailfold capillaroscopy in patients with systemic sclerosis-associated interstitial lung disease: a substudy of the SENSCIS trialVanessa Smith, Christopher P Denton, Ariane L Herrick, et al.Plastic and Reconstructive Surgery|March 26, 2025
Long-term outcome of fat grafting to treat facial Systemic Sclerosis: a prospective cohort studyAurora Almadori, Michelle Griffin, Jeon Hyun, et al.Thrombosis and Haemostasis|February 6, 2015
Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditionsGerhard Dickneite, Heiko Herwald, Wolfgang Korte, et al.Rheumatology (Oxford, England)|June 10, 2010
Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centreNora M Thoua, Catey Bunce, Geraldine Brough, et al.Arthritis and Rheumatism|January 3, 2013
Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertensionChristopher J Valerio, Benjamin E Schreiber, Clive E Handler, et al.Nature Reviews. Disease Primers|May 19, 2016
Systemic sclerosisYannick Allanore, Robert Simms, Oliver Distler, et al.Clinical and Experimental Rheumatology|June 14, 2012
Clinical trial design in scleroderma: where are we and where do we go next?Lorinda Chung, Christopher P Denton, Oliver Distler, et al.Autoimmunity Reviews|February 17, 2020
Gender-related differences in systemic sclerosisMichael Hughes, John D Pauling, Laura Armstrong-James, et al.Rheumatology (Oxford, England)|August 22, 2009
A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosisSvetlana I Nihtyanova, Jennifer C Parker, Carol M Black, et al.Pageof 46